Lenalidomide and Dexamethasone With or Without Thalidomide in Treating Patients With Multiple Myeloma
Lenalidomide and Dexamethasone With or Without Thalidomide in Treating Patients With Multiple Myeloma
Active, not recruiting · NCT00098475 · Registry updated 2026-08-28Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Lenalidomide and Dexamethasone With or Without Thalidomide in Treating Patients With Multiple Myeloma | DS Stage I Multiple Myeloma; DS Stage II Multiple Myeloma; DS Stage III Multiple Myeloma | Active, not recruiting | Phase 3 | 2026-08-28 | NCT00098475 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| National Cancer Institute (NCI) | 3015 |
138 results · Page 1 of 6
Research sites
Swipe the table sideways for more columns.